Pipeline Overview
Our expanding development program currently includes four repurposed drugs, in different phases of development.
| Code | Indication | Drug Status | Human Efficacy | Patent Protection | Regulatory Pathway |
|---|---|---|---|---|---|
| OP001 | Opioid Addiction | Reformulated generic | Yes | Pending | 505(B)(2) |
| OP002 | Pain Reduction Alternative in Opioid Users | Reformulated generic | Yes | Pending | 505(B)(2) |
| OP003 | Prevention of Opioid Induced Respiratory Depression | Reformulated generics combination | Yes | Pending | 505(B)(2) |
| OP004 | Enhanced Effect Lower Dose Opioids for Pain Relief | Reformulated generics combination | Yes | Pending | 505(B)(2) |